» Articles » PMID: 17554648

The Utility of Contrast-enhanced Endoscopic Ultrasound in Monitoring Ethanol-induced Pancreatic Tissue Ablation: a Pilot Study in a Porcine Model

Overview
Journal Endoscopy
Date 2007 Jun 8
PMID 17554648
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Study Aims: Pancreatic ablation is gaining popularity for the treatment of focal pancreatic lesions. The aim of our study was to evaluate local effects of intrapancreatic alcohol injection and the utility of contrast-enhanced endoscopic ultrasound (EUS) for its monitoring in a porcine model.

Methods: We performed four survival experiments on 50-kg pigs. Under linear EUS guidance, 0.5 mL of 50% ethanol plus purified carbon particle solution (GI Spot) was injected into the pancreatic body to create a focal area of pancreatic necrosis. The animals survived for 24-48 hours (pigs # 1, # 2, and # 3) and 7 days (pig # 4). EUS was then repeated with and without perflutren lipid microspheres (Definity) administration through the peripheral vein. Standard and microsphere-enhanced images of the pancreas were compared. Afterwards the animals were euthanized for necropsy.

Results: Alcohol injection caused focal pancreatic necrosis, which was barely seen by standard EUS as a subtle hypoechoic lesion 1 cm in diameter. Color and power Doppler EUS of this region did not reveal any blood flow. After intravenous injection of microspheres, color Doppler EUS revealed marked contrast enhancement of normal pancreatic parenchyma with a clearly delineated avascular alcohol-treated area, which on postmortem examination corresponded to the discrete necrotic area marked with carbon particles.

Conclusions: EUS-guided alcohol injection consistently causes focal areas of pancreatic necrosis. Contrast-enhanced EUS with microspheres improves visualization of altered pancreatic vascular perfusion and can be used to facilitate detection of small pancreatic lesions and its follow-up post-ablation.

Citing Articles

Endoscopy-guided ablation of pancreatic lesions: Technical possibilities and clinical outlook.

Signoretti M, Valente R, Repici A, Delle Fave G, Capurso G, Carrara S World J Gastrointest Endosc. 2017; 9(2):41-54.

PMID: 28250896 PMC: 5311472. DOI: 10.4253/wjge.v9.i2.41.


Applications of contrast-enhanced harmonic endoscopic ultrasound on biliary, focal liver lesions and vascular diseases.

Choi J, Seo D Endosc Ultrasound. 2017; 6(1):21-24.

PMID: 28218196 PMC: 5331838. DOI: 10.4103/2303-9027.200211.


Dynamic contrast-enhanced endoscopic ultrasound: A quantification method.

Dietrich C, Dong Y, Froehlich E, Hocke M Endosc Ultrasound. 2017; 6(1):12-20.

PMID: 28218195 PMC: 5331837. DOI: 10.4103/2303-9027.193595.


Endoscopic ultrasound in pancreatic cancer: innovative applications beyond the basics.

Yoo J, Kistler C, Yan L, Dargan A, Siddiqui A J Gastrointest Oncol. 2017; 7(6):1019-1029.

PMID: 28078128 PMC: 5177581. DOI: 10.21037/jgo.2016.08.07.


The role of contrast-enhanced endoscopic ultrasound in pancreatic adenocarcinoma.

Saftoiu A, Vilmann P, Bhutani M Endosc Ultrasound. 2016; 5(6):368-372.

PMID: 28000627 PMC: 5206824. DOI: 10.4103/2303-9027.190932.